| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 38.7547 | 4 |
| GSM780708 | Untreated after 4 days (C2_1) | 39.0779 | 4 |
| GSM780709 | Untreated after 4 days (C3_1) | 39.888 | 6 |
| GSM780719 | Untreated after 4 days (C1_2) | 41.8781 | 13 |
| GSM780720 | Untreated after 4 days (C2_2) | 40.2469 | 7 |
| GSM780721 | Untreated after 4 days (C3_2) | 44.5215 | 25 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 33.4873 | 1 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 39.6309 | 5 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 38.0452 | 3 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 43.617 | 20 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 43.6185 | 20 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 43.8703 | 22 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 32.6223 | 1 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 37.9972 | 3 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 37.6977 | 2 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 44.4836 | 25 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 44.2602 | 23 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 41.3995 | 11 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 38.191 | 3 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 41.6491 | 12 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 40.1021 | 7 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 37.7716 | 2 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 36.764 | 1 |